To characterize the mechanism through which chemotherapeutic drugs down-regulate KLF5 expression in BLBC, we searched the literature and found that FOXO1 induces KLF5 transcription and causes oxidative stress in diabetic cardiomyopathy.5 This evidence concerns the gene KLF5 and diabetic cardiomyopathy.